ACIPHEX Is Approved For GERD Treatment In Adolescents
ACIPHEX (rabeprazole Sodium) is a prescription medication that was discovered and developed by Eisai and is copromoted in the United States with PriCara(R), a Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.. This gerd medication is used in adults for the short-term (4 to 8 weeks) treatment of damaging (erosive) Gastroesophageal Reflux Disease (GERD), for the treatment of day-time and night-time heartburn and other symptoms that happen with GERD and to maintain healing of damage (erosions) and relief of heartburn symptoms with GERD.
ACIPHEX 20 mg once daily is now also indicated for young patients of 12 and above for the short-term treatment (up to 8 weeks) for heartburn and other GERD symptoms.
It has been known that the Food and Drug Administration (FDA) has approved ACIPHEX (rabeprazole sodium) 20 mg for the short-term (up to eight weeks) treatment of gastroesophageal reflux disease (GERD) in adolescents ages 12 and above.
The multi-center, open-label, randomized, parallel-group study included 111 adolescent GERD patients and lasted 12 weeks. All patients well tolerated generic Aciphex and the negative events that took place: headache, diarrhea, nausea, vomiting and abdominal pain didn’t refer to relationship to ACIPHEX drug.
This research revealed that ACIPHEX medication is effective in reducing the severity and frequency of GERD symptoms.
Therefore, once-daily treatment with Rabeprazole 20 mg is approved for short-term treatment (eight weeks) of GERD in adolescents. And you can order Aciphex online.
